Press "Enter" to skip to content

New patent for Anacor Pharms drug KERYDIN

0
Copyright © DrugPatentWatch. Originally published at New patent for Anacor Pharms drug KERYDIN

Annual Drug Patent Expirations for KERYDIN
Annual Drug Patent Expirations for KERYDIN

Kerydin is a drug marketed by Anacor Pharms Inc and is included in one NDA. It is available from one supplier. There are five patents protecting this drug and one Paragraph IV challenge.

KERYDIN drug price trends.

Drug patent litigation for KERYDIN.

The generic ingredient in KERYDIN is tavaborole. One supplier is listed for this compound. Additional details are available on the tavaborole profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Anacor Pharms drug KERYDIN
    Get the DrugPatentWatch Daily Briefing

    ✓ Patent Expirations and Generic Entry

    ✓ Insightful Articles & Case Studies

    ✓ Patent Litigation & Challenges

    ✓ 505(b)(2) & Biosimilars

    ✓ Industry Trends

    DrugPatentWatch - Make Better Decisions